submit url • add directory • Physical Therapy jobs ♦ Registered Nurse jobs
Today's News:
Annals of Hematology (Online First™)
Nine years interval between first and second bone marrow transplantations and subsequent long-term survival—a case of acute myeloid leukemia with MLL-AF6 fusion gene
Fri, 03 Feb 2012 17:12:41 -0000
Nine years interval between first and second bone marrow transplantations and subsequent long-term survival—a case of acute myeloid leukemia with MLL-AF6 fusion gene Content Type Journal ArticleCategory Letter to the EditorPages 1-3DOI 10.1007/s00277-012-1417-2Authors Yasuhisa Yokoyama, Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, JapanKazumi Suzukawa, Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, JapanYasushi Okoshi, Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, JapanToru Nanmoku, Department of Clinical Laboratory, Tsukuba University Hospital, Tsukuba, Ibaraki, JapanNaoshi Obara, Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, JapanTerukazu Enami, Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, JapanYuichi Hasegawa, Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, JapanShigeru Chiba, Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, Japan Journal Annals of HematologyOnline ISSN 1432-0584Print ISSN 0939-5555
Kinetics of blood CD34+ cells after chemotherapy plus G-CSF in poor mobilizers: Implications for pre-emptive plerixafor use
Thu, 02 Feb 2012 18:15:06 -0000
Abstract Mobilization and collection of stem cells is difficult in a proportion of patients intended for autologous stem cell transplantation (ASCT). We have evaluated mobilization kinetics of blood CD34+ cells (B-CD34+) to form basis for algorithm to facilitate rational pre-emptive plerixafor use. Altogether 390 chemomobilized patients were included. Forty-three patients (11%) did not reach B-CD34+ count ≥10 × 106/l. Mobilization kinetics differed according to the mobilization capacity observed. Among those who were very poor or inadequate mobilizers (peak B-CD34+ count ≤5 × 106/l and 6–10 × 106/l, respectively), B-CD34+ counts rarely rose after white blood cells (WBC) >5–10 × 109/l, whereas in many standard mobilizers a later rise in CD34+ counts could be observed. Four algorithms based on WBC and CD34+ counts were constructed. According to this patient series, algorithm II (WBC >5 × 109/l and B-CD34+ ≤10 × 106/l) and algorithm IV (WBC >10 × 109/l and B-CD34+ ≤10 × 109/l) were the most applicable. For algorithm II the sensitivity was 0.97 and specificity 1.00, respectively, to identify patients for plerixafor use provided that all patients with B-CD34+ maximum ≤10 × 106/l would have needed plerixafor. This simple model needs a prospective validation. Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s00277-012-1411-8Authors E. Jantunen, University of Eastern Finland/Clinical Medicine, Kuopio, FinlandV. Varmavuo, Department of Medicine, Kuopio University Hospital, P.O.B. 1777, 70211 Kuopio, FinlandA. Juutilainen, University of Eastern Finland/Clinical Medicine, Kuopio, FinlandT. Kuittinen, Department of Medicine, Kuopio University Hospital, P.O.B. 1777, 70211 Kuopio, FinlandE. Mahlamäki, Laboratory of Eastern Finland, Kuopio, FinlandP. Mäntymaa, Laboratory of Eastern Finland, Kuopio, FinlandT. Nousiainen, Department of Medicine, Kuopio University Hospital, P.O.B. 1777, 70211 Kuopio, Finland Journal Annals of HematologyOnline ISSN 1432-0584Print ISSN 0939-5555
Primary MALT lymphoma of the urinary bladder in the background of interstitial cystitis
Thu, 02 Feb 2012 06:56:37 -0000
Primary MALT lymphoma of the urinary bladder in the background of interstitial cystitis Content Type Journal ArticleCategory Letter to the EditorPages 1-2DOI 10.1007/s00277-012-1419-0Authors Ken Morita, Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanFumihiko Nakamura, Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanYasuhito Nannya, Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanAkira Nomiya, Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanShunya Arai, Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanMotoshi Ichikawa, Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanYukio Homma, Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanMineo Kurokawa, Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 Japan Journal Annals of HematologyOnline ISSN 1432-0584Print ISSN 0939-5555
Permanent Hematology-Oncology Jobs
Hematology-Oncology jobs
Tue, 07 Feb 2012 14:23:56 -0500
All Hematology-Oncology jobs for Tue Feb 7 2012
Hematology-Oncology jobs in "Hospital Based Practice Opportunity for an Oncologist in the Southeast" - GA
Tue, 20 Dec 2011 13:27:44 -0500
Job 941229 Hospital Based Practice Opportunity for an Oncologist in the Southeast Join 4 Oncologists in an expanding practice Practicing physicians and fellows will all be considered Clinical trials
Hematology-Oncology jobs in "Hospital Employed Hematology Oncology Opportunity in Southern Virginia" - VA
Tue, 20 Dec 2011 13:27:44 -0500
Job 921917 Hospital is recruiting 2 Oncologist to make their program a 3 person group. The hospital will offer a full patient base upon arrival and great security. Compensation will be based on MGMA
Subscribe to Hematology RSS feed 
Nine years interval between first and second bone marrow transplantations and subsequent long-term survival—a case of acute myeloid leukemia with MLL-AF6 fusion gene
Fri, 03 Feb 2012 17:12:41 -0000
Nine years interval between first and second bone marrow transplantations and subsequent long-term survival—a case of acute myeloid leukemia with MLL-AF6 fusion gene Content Type Journal ArticleCategory Letter to the EditorPages 1-3DOI 10.1007/s00277-012-1417-2Authors Yasuhisa Yokoyama, Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, JapanKazumi Suzukawa, Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, JapanYasushi Okoshi, Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, JapanToru Nanmoku, Department of Clinical Laboratory, Tsukuba University Hospital, Tsukuba, Ibaraki, JapanNaoshi Obara, Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, JapanTerukazu Enami, Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, JapanYuichi Hasegawa, Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, JapanShigeru Chiba, Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1, Tennodai, Tsukuba, Ibaraki, Japan Journal Annals of HematologyOnline ISSN 1432-0584Print ISSN 0939-5555
Kinetics of blood CD34+ cells after chemotherapy plus G-CSF in poor mobilizers: Implications for pre-emptive plerixafor use
Thu, 02 Feb 2012 18:15:06 -0000
Abstract Mobilization and collection of stem cells is difficult in a proportion of patients intended for autologous stem cell transplantation (ASCT). We have evaluated mobilization kinetics of blood CD34+ cells (B-CD34+) to form basis for algorithm to facilitate rational pre-emptive plerixafor use. Altogether 390 chemomobilized patients were included. Forty-three patients (11%) did not reach B-CD34+ count ≥10 × 106/l. Mobilization kinetics differed according to the mobilization capacity observed. Among those who were very poor or inadequate mobilizers (peak B-CD34+ count ≤5 × 106/l and 6–10 × 106/l, respectively), B-CD34+ counts rarely rose after white blood cells (WBC) >5–10 × 109/l, whereas in many standard mobilizers a later rise in CD34+ counts could be observed. Four algorithms based on WBC and CD34+ counts were constructed. According to this patient series, algorithm II (WBC >5 × 109/l and B-CD34+ ≤10 × 106/l) and algorithm IV (WBC >10 × 109/l and B-CD34+ ≤10 × 109/l) were the most applicable. For algorithm II the sensitivity was 0.97 and specificity 1.00, respectively, to identify patients for plerixafor use provided that all patients with B-CD34+ maximum ≤10 × 106/l would have needed plerixafor. This simple model needs a prospective validation. Content Type Journal ArticleCategory Original ArticlePages 1-7DOI 10.1007/s00277-012-1411-8Authors E. Jantunen, University of Eastern Finland/Clinical Medicine, Kuopio, FinlandV. Varmavuo, Department of Medicine, Kuopio University Hospital, P.O.B. 1777, 70211 Kuopio, FinlandA. Juutilainen, University of Eastern Finland/Clinical Medicine, Kuopio, FinlandT. Kuittinen, Department of Medicine, Kuopio University Hospital, P.O.B. 1777, 70211 Kuopio, FinlandE. Mahlamäki, Laboratory of Eastern Finland, Kuopio, FinlandP. Mäntymaa, Laboratory of Eastern Finland, Kuopio, FinlandT. Nousiainen, Department of Medicine, Kuopio University Hospital, P.O.B. 1777, 70211 Kuopio, Finland Journal Annals of HematologyOnline ISSN 1432-0584Print ISSN 0939-5555
Primary MALT lymphoma of the urinary bladder in the background of interstitial cystitis
Thu, 02 Feb 2012 06:56:37 -0000
Primary MALT lymphoma of the urinary bladder in the background of interstitial cystitis Content Type Journal ArticleCategory Letter to the EditorPages 1-2DOI 10.1007/s00277-012-1419-0Authors Ken Morita, Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanFumihiko Nakamura, Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanYasuhito Nannya, Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanAkira Nomiya, Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanShunya Arai, Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanMotoshi Ichikawa, Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanYukio Homma, Department of Urology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 JapanMineo Kurokawa, Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655 Japan Journal Annals of HematologyOnline ISSN 1432-0584Print ISSN 0939-5555
Permanent Hematology-Oncology Jobs
Hematology-Oncology jobs
Tue, 07 Feb 2012 14:23:56 -0500
All Hematology-Oncology jobs for Tue Feb 7 2012
Hematology-Oncology jobs in "Hospital Based Practice Opportunity for an Oncologist in the Southeast" - GA
Tue, 20 Dec 2011 13:27:44 -0500
Job 941229 Hospital Based Practice Opportunity for an Oncologist in the Southeast Join 4 Oncologists in an expanding practice Practicing physicians and fellows will all be considered Clinical trials
Hematology-Oncology jobs in "Hospital Employed Hematology Oncology Opportunity in Southern Virginia" - VA
Tue, 20 Dec 2011 13:27:44 -0500
Job 921917 Hospital is recruiting 2 Oncologist to make their program a 3 person group. The hospital will offer a full patient base upon arrival and great security. Compensation will be based on MGMA
Sites:
BloodLine: BloodLine is dedicated to furthering and enhancing the fields of hematology and oncology through the presentation of knowledge in the following manners: the publication of original clinical and laboratory research; the creation of comprehensive reference works that are continuously useful to...Atlas of hematology: The Atlas of Haematology contains about 700 illustrations of blood and bone marrow cells
Atlas of Hematology: CDROM Atlas of hematology with 1500 color images, by Prof. John Meletis. Range of examples available online.
Atlas of Hematology: Contains images of blood cells with descriptions.
Aurea R. Tomeski, M.D.: Dr. Tomeski - Internal Medicine - Hematology - Oncology
BloodMed: BloodMed.com - The global source for hematology education, practice and research
European Federation for Immunogenetics: Website for the European Federation of Immunogenetics.
Factor Replacement by Continuous Infusion: Guide for health professionals who provide continuous infusion clotting factor replacement therapy to individuals with bleeding disorders. Describes theory behind how to prescribe, administer, and monitor replacement therapy.
Family Practice Notebook: Hematology and Oncology: Find chapters about Anemia, Cancer, Coagulopathy, Examination, Hemoglobin, Hemolysis, Histiocytosis, Leukemia, Lymph, Marrow, Platelet, Procedure, Sarcoma, Symptom Evaluation and Vascular. Related chapters from other specialties include Cardiovascular, Dermatology, Endocrinology, Otolaryngology,...
General Practice Notebook - Haematology: Coverage of this medical speciality.
Haem.net: Haem.net - The Web Journal of Laboratory Haematology to serve the educational needs of anyone with an interest in Laboratory Haematology in the U.K. and overseas
Haematological Malignancy Diagnostic Service: The diagnosis of leukaemia, lymphoma, myeloma and related blood disorders by cellular and molecular investigation. Contents include the current classification of the myeloproliferative and lymphoproliferative disorders, morphology and cytochemistry, and diagnostic procedures including antibody ba...
Haematology: Haematology & Pathology Education Website for medical laboratory officer`s student or a clinical haematologist in training. Contains an Interactice questions and answers style haematology atlas set of slides. its an online hematology book. particularly useful for hematologists and pathologist...
Hematology: Wikipedia article describing branch of medicine, related diseases, tests, and treatments.
Hematology and Oncology Associates Of Virginia: Virginia Cancer Institute is dedicated to the highest quality medical care for the treatment of diseases of the blood (hematology) to the long-term management of cancer for our patients .
Hematology jobs: Hematology jobs at Physician Employment with automatic email updates.
Hematology, by Ellen C. Ebert, MD: Grant-funded research report which requires the Adobe Acrobat Reader to view.
Hematopathology Correlative Pathology Course: From the UAB Department of Pathology, Birmingham, Alabama.
Machaon Diagnostics: Clinical reference laboratory developing products for diagnosis and monitoring of hemostatic and thrombotic conditions.
Ortho-WIRE: Educational resource for transfusion medicine applications in immuno-hematology, blood group serology, and hemolytic disease of the newborn.
The Vanderbilt Hemostasis-Thrombosis Clinic: The Vanderbilt Hemostasis-Thrombosis Clinic provides comprehensive care for inherited disorders of bleeding or coagulation. Committed to patient care, education, and clinical research, we have over 75 years of experience caring for people with hemophilia, thrombophilia, and other blood disorders.
This directory is based on the Open Directory and may have been modified